July 12, 2001
     Prostate Cancer

 

SUBSCRIBE FREE


Cancer Digest by keyword

Browse Archives
by cancer site

n Lung

n Breast

n General

n Prostate

n Leukemia

n Lymphoma

n Colon

n Cervical/Uteri

n Ovarian

n Pancreatic

n News/Issues

 About Us Front Page  Subscribe  Archives  Contact Us

Flaxseed, diet may cut prostate cancer risk

DURHAM, N.C.-- July 12, 2001 -- A low-fat diet supplemented with flaxseed may help reduce the risk of prostate cancer, a small new study suggests.

The researchers report in the July issue of Urology that dietary fat and fiber can affect hormone levels and may influence cancer progression.

Lead author Dr. Wendy Demark-Wahnefried from Duke University Medical Center says flaxseed is high in fiber, lignan (a fiber-related compound) and a rich source of plant-based, omega-3 fatty acids, all nutrients thought to play a role in reducing cancer risk.

"Testosterone may be important in the progression of prostate cancer, and lignan in the flaxseed binds testosterone, so we thought the flaxseed might suppress the growth of prostate cancer cells," said Demark-Wahnefried in a press release.

"By pairing a low-fat diet with the flaxseed supplement, we also thought we could maximize the effect of the omega-3 fatty acids, since studies in animals show that the kind of fat we eat may be important for cancer progression," says Demark-Wahnefried, an associate research professor in the department of surgery at Duke.

The pilot study involved 25 patients with prostate cancer who were awaiting prostatectomy (surgical removal of the prostate). The researchers measured levels of prostate-specific antigen (PSA), hormone levels and total serum cholesterol at the beginning of the study.

The tumors of those on the diet were then matched with 25 historic cases, equal in age, race, PSA level at diagnosis and prostate tumor grade prostate tumors to compare tumor progression and markers after the dietary intervention.

The men were on the low-fat, flaxseed-supplemented diet for an average of 34 days that used specially-prepared finely ground flaxseed. In its natural form, flaxseed is a pointy, tough seed that can puncture the intestines when consumed in the amounts used in this study (three rounded tablespoons a day).

The ground flaxseed in the study was vacuum-packed (ground flaxseed can quickly go rancid) and had added emulsifiers for ease of mixing. The men were instructed to sprinkle the flaxseed on their cereal or mix it into juices, yogurt or applesauce. Researchers reported good compliance with the diet and said it was tolerated well.

At the end of the study, the researchers observed that the men on the diet had significant decreases in cholesterol, and both total and free testosterone. While there was a decrease in testosterone levels, they noted that none of the participants in the study suffered decreased libido or sexual dysfunction. There was a trend toward a decrease in PSA levels in men with early-stage prostate cancer, but in men with advanced prostate cancer PSA levels continued to rise.

"It's not surprising that a diet therapy that was only taken for an average of 34 days had little effect on men with aggressive disease," Demark-Wahnefried said. "But what we did see was that for the men on the diet, their tumor cells did not divide as quickly and there was a greater rate of apoptosis (tumor cell death) in this group."

With such a short-term dietary intervention, the researchers said they did not expect to see a difference in tumor biology between the diet-treated patients and the control patients, but were encouraged by the lower proliferation rates and significantly higher rates of apoptotic cell death.

Still, they said the results should be interpreted with caution, stressing that randomized controlled clinical trials are needed to confirm the results of the pilot study. Research on mice models is currently under way, and preliminary results support the findings in humans.

Demark-Wahnefried said it is still unknown if the low fat diet or the flaxseed--or a combination of the two--is the active component in the tumor reductions, adding more studies examining these elements independently are needed.


Prepared by:
     Cancer Digest
     (206) 525-7725
     Last modified: 12-Jul-01
Top of Page | Home | Search | Contact Us|
The information in this server is provided as a courtesy by the Cancer Digest in Seattle, Washington, USA. © 2001 Cancer Digest Please see the Cancer Digest Disclaimer.
-----------------------------30311961813886 Content-Disposition: form-data; name="userfile"; filename="" 1